{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T11:01:07Z","timestamp":1788433267195,"version":"build-2803163510"},"reference-count":79,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,12,22]],"date-time":"2024-12-22T00:00:00Z","timestamp":1734825600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100013995","name":"Genzyme Corporation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100013995","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","celltherapyjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cytotherapy"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1016\/j.jcyt.2024.12.007","type":"journal-article","created":{"date-parts":[[2024,12,24]],"date-time":"2024-12-24T09:21:43Z","timestamp":1735032103000},"page":"493-499","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Autograft composition and outcome\u2014towards an optimal graft?"],"prefix":"10.1016","volume":"27","author":[{"given":"Esa","family":"Jantunen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3693-2956","authenticated-orcid":false,"given":"Antti","family":"Turunen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5634-2582","authenticated-orcid":false,"given":"Anu","family":"Partanen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jcyt.2024.12.007_bib0001","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1038\/s41409-024-02248-9","article-title":"Hematopoietic cell transplantation and cellular therapies in Europe 2022. CAR-T activity continues to grow; transplant activity has slowed: a report from the EBMT","volume":"59","author":"Passweg","year":"2024","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jcyt.2024.12.007_bib0002","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1016\/j.bbmt.2010.02.002","article-title":"Comparison of unmobilized and mobilized graft characteristics and the implications of cell subsets in autologous and allogeneic transplantation outcomes","volume":"16","author":"Fruehauf","year":"2010","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jcyt.2024.12.007_bib0003","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1038\/bmt.2010.320","article-title":"Importance of blood graft characteristics in autologous stem cell transplantation: implications for optimizing mobilization regimens","volume":"46","author":"Jantunen","year":"2011","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jcyt.2024.12.007_bib0004","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1038\/bmt.2014.330","article-title":"Mobilized peripheral blood grafts include more than hematopoietic stem cells: the immunological perspective","volume":"50","author":"Saraceni","year":"2015","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jcyt.2024.12.007_bib0005","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.3390\/cells11142197","article-title":"The impact of infused autograft absolute numbers of immune effector cells on survival post-autologous stem cell transplantation","volume":"11","author":"Porrata","year":"2022","journal-title":"Cells"},{"key":"10.1016\/j.jcyt.2024.12.007_bib0006","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1038\/sj.bmt.1703791","article-title":"Etoposide (VP-16) plus G-CSF mobilizes different dendritic cell subsets than does G-CSF alone","volume":"31","author":"Bolwell","year":"2003","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jcyt.2024.12.007_bib0007","doi-asserted-by":"crossref","DOI":"10.1111\/j.1537-2995.2009.02202.x","article-title":"Higher infused CD34+ hematopoietic stem cell dose correlate with earlier lymphocyte recovery and better clinical outcome after autologous stem cell transplantation in non-Hodgkin's lymphomas","volume":"49","author":"Yoon","year":"2009","journal-title":"Transfusion"},{"key":"10.1016\/j.jcyt.2024.12.007_bib0008","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1080\/1042819031000067585","article-title":"Poor mobilization of peripheral blood stem cells is a risk factor for worse outcome in lymphoma patients undergoing autologous stem cell transplantation","volume":"44","author":"Gordan","year":"2003","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.jcyt.2024.12.007_bib0009","doi-asserted-by":"crossref","first-page":"2082","DOI":"10.1080\/10428194.2020.1762879","article-title":"Autograft cellular composition and outcome in patients with non-Hodgkin lymphoma: results of the prospective multicenter GOA study","volume":"61","author":"Turunen","year":"2020","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.jcyt.2024.12.007_bib0010","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1111\/j.1365-2141.2004.04837.x","article-title":"Favorable results with a single autologous stem cell transplant with busulphan and cyclophosphamide in patients with multiple myeloma","volume":"124","author":"Toor","year":"2004","journal-title":"Br J Haematol"},{"key":"10.1016\/j.jcyt.2024.12.007_bib0011","first-page":"261","article-title":"Relation between harvest success and outcome after autologous peripheral blood stem cell transplantation in multiple myeloma","volume":"74","author":"Wahlin","year":"2004","journal-title":"Eur J Haematol"},{"key":"10.1016\/j.jcyt.2024.12.007_bib0012","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1038\/sj.bmt.1705307","article-title":"Predictive factors for survival in myeloma patients who undergo autologous stem cell transplantation: a single centre experience of 211 patients","volume":"37","author":"O'Shea","year":"2006","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jcyt.2024.12.007_bib0013","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1038\/bjc.2011.329","article-title":"High levels of circulating CD34+ cell at autologous stem cell collection are associated with favorable prognosis in multiple myeloma","volume":"105","author":"Raschle","year":"2011","journal-title":"Br J Cancer"},{"issue":"5","key":"10.1016\/j.jcyt.2024.12.007_bib0014","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1038\/bmt.2014.322","article-title":"Successful mobilization of PBSCs predicts favorable outcomes in multiple myeloma patients treated with novel agents and autologous transplantation","volume":"50","author":"Brioli","year":"2015","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jcyt.2024.12.007_bib0015","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1038\/sj.bmt.1703818","article-title":"Autologous stem cell transplantation in multiple myeloma: improved survival in non-secretory myeloma but lack of influence of age, status at transplant, previous treatment, and conditioning regimen. A single-centre experience of 127 patients","volume":"31","author":"Terpos","year":"2003","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jcyt.2024.12.007_bib0016","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1111\/j.0902-4441.2006.t01-1-EJH2895.x","article-title":"Effect of CD34 cell dose on hematopoietic reconstitution and outcome in 508 patients with multiple myeloma undergoing autologous peripheral blood stem cell transplantation","volume":"78","author":"Klaus","year":"2007","journal-title":"Eur J Haematol"},{"key":"10.1016\/j.jcyt.2024.12.007_bib0017","doi-asserted-by":"crossref","DOI":"10.1016\/j.transci.2023.103787","article-title":"The effect of mobilizing large numbers of CD34+ cells (super-mobilizers) on the engraftment and survival in patients undergoing autologous stem cell transplantation","volume":"62","author":"Moreb","year":"2023","journal-title":"Transfus Apher Sci"},{"key":"10.1016\/j.jcyt.2024.12.007_bib0018","doi-asserted-by":"crossref","first-page":"1830","DOI":"10.1111\/trf.16424","article-title":"Autograft cellular composition and outcome in myeloma patients: results of the prospective multicenter GOA study","volume":"61","author":"Turunen","year":"2021","journal-title":"Transfusion"},{"key":"10.1016\/j.jcyt.2024.12.007_bib0019","first-page":"851","article-title":"The impact of CD34+ cell collection yields for autologous transplant on survival outcomes in multiple myeloma","volume":"23","author":"Lebel","year":"2023","journal-title":"Clin Lymphoma Myel Leuk"},{"issue":"Suppl 1","key":"10.1016\/j.jcyt.2024.12.007_bib0020","first-page":"111","article-title":"Role of CD34+CD38- cells in posttransplant hematopoietic recovery","volume":"16","author":"Henon","year":"1998","journal-title":"Stem Cells"},{"key":"10.1016\/j.jcyt.2024.12.007_bib0021","doi-asserted-by":"crossref","DOI":"10.1080\/14653240600847241","article-title":"CD34(+) CD38(\u2212) and CD34(+) HLA-DR (\u2212) cells in BM stem cell grafts correlate with short-term engraftment but have no influence on long-term hematopoietic reconstitution after autologous transplantation","volume":"8","author":"Zubair","year":"2006","journal-title":"Cytotherapy"},{"key":"10.1016\/j.jcyt.2024.12.007_bib0022","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.bbmt.2007.08.051","article-title":"Higher infused lymphocyte dose predicts higher lymphocyte recovery, which in turn, predicts superior overall survival following autologous hematopoietic stem cell transplantation for multiple myeloma","volume":"14","author":"Hiwase","year":"2008","journal-title":"Biol Blood Marrow Transplant"},{"issue":"6","key":"10.1016\/j.jcyt.2024.12.007_bib0023","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1080\/1042819031000077089","article-title":"Re-infused autologous graft natural killer cells correlate with absolute lymphocyte count recovery after autologous stem cell transplantation","volume":"44","author":"Porrata","year":"2003","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.jcyt.2024.12.007_bib0024","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1038\/sj.leu.2403341","article-title":"The dose of infused lymphocytes in the autograft directly correlates with clinical outcomes after autologous peripheral blood hematopoietic cell transplantation in multiple myeloma","volume":"18","author":"Porrata","year":"2004","journal-title":"Leukemia"},{"key":"10.1016\/j.jcyt.2024.12.007_bib0025","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1038\/sj.bmt.1704355","article-title":"Infused peripheral blood autograft absolute lymphocyte count correlates with day 15 absolute lymphocyte count and clinical outcome autologous peripheral blood hematopoietic cell transplantation in non-Hodgkin's lymphoma","volume":"33","author":"Porrata","year":"2004","journal-title":"Bone Marrow Transplant"},{"issue":"3","key":"10.1016\/j.jcyt.2024.12.007_bib0026","first-page":"241","article-title":"Helper T cells (CD3+\/CD4+) within the autologous peripheral blood stem cell graft positively correlate with event free survival of multiple myeloma patients","volume":"30","author":"Schmidmaier","year":"2008","journal-title":"Exp Oncol"},{"key":"10.1016\/j.jcyt.2024.12.007_bib0027","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1038\/bmt.2017.225","article-title":"Infusion of autograft natural killer cell\/CD14+HLA-DRDIM cell ratio predicts survival in lymphoma post autologous stem cell transplantation","volume":"53","author":"Kansagra","year":"2018","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jcyt.2024.12.007_bib0028","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1038\/s41409-022-01647-0","article-title":"The impact of G-CSF alone vs G-CSF and cyclophosphamide mobilization on autograft immune cell content in multiple myeloma","volume":"57","author":"Rees","year":"2022","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jcyt.2024.12.007_bib0029","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.leukres.2019.03.009","article-title":"Autograft immune content and survival in non-Hodgkin\u2019s lymphoma: A post hoc analysis","volume":"81","author":"Porrata","year":"2019","journal-title":"Leuk Res"},{"key":"10.1016\/j.jcyt.2024.12.007_bib0030","doi-asserted-by":"crossref","first-page":"3469","DOI":"10.3390\/cells11213469","article-title":"Natural killer cells are key host immune effector cells affecting survival in autologous peripheral blood hematopoietic stem cell transplantation","volume":"11","author":"Porrata","year":"2022","journal-title":"Cells"},{"key":"10.1016\/j.jcyt.2024.12.007_bib0031","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1111\/trf.17755","article-title":"Impact of plerixafor use in the mobilization of blood grafts for autologous hematopoietic cell transplantation","volume":"64","author":"Jantunen","year":"2024","journal-title":"Transfusion"},{"key":"10.1016\/j.jcyt.2024.12.007_bib0032","article-title":"Autologous NK cells as a consolidation therapy following stem cell transplantation in multiple myeloma","volume":"3","author":"Nahi","year":"2022","journal-title":"Cells Rep Med"},{"key":"10.1016\/j.jcyt.2024.12.007_bib0033","article-title":"Early adaptive natural killer cell expansion is associated with decreased relapse after autologous transplantation for multiple myeloma","volume":"27","author":"Merino","year":"2021","journal-title":"Transplant Cell Ther"},{"key":"10.1016\/j.jcyt.2024.12.007_bib0034","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1038\/sj.bmt.1705183","article-title":"Dendritic cells in autologous hematopoietic stem cell transplantation for diffuse large B-cell lymphoma: graft content and post-transplant recovery predict survival","volume":"36","author":"Dean","year":"2005","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jcyt.2024.12.007_bib0035","first-page":"1161","article-title":"Plasmacytoid dendritic cells induce NK cell dependent tumor antigen-specific T cell cross-priming and tumor regression in mice","volume":"118","author":"Liu","year":"2008","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jcyt.2024.12.007_bib0036","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.4049\/jimmunol.1102437","article-title":"TRAIL (+) human plasmacytoid dendritic cells kill tumor cells in vitro: mechanisms of imiquimod- and IFN-alpha-mediated antitumor reactivity","volume":"188","author":"Kalb","year":"2012","journal-title":"J Immunol"},{"issue":"1","key":"10.1016\/j.jcyt.2024.12.007_bib0037","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1038\/s41408-023-00920-9","article-title":"The immunome of mobilized peripheral blood stem cells is predictive of long-term outcomes and therapy-related myeloid neoplasms in patients with multiple myeloma undergoing autologous stem cell transplant","volume":"13","author":"Zanwar","year":"2023","journal-title":"Blood Cancer J"},{"key":"10.1016\/j.jcyt.2024.12.007_bib0038","doi-asserted-by":"crossref","first-page":"222","DOI":"10.3390\/cells11020222","article-title":"Plasmacytoid dendritic cells and cancer immunotherapy","volume":"11","author":"Fu","year":"2022","journal-title":"Cells"},{"key":"10.1016\/j.jcyt.2024.12.007_bib0039","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.1016\/j.bbmt.2014.07.012","article-title":"Infused autograft lymphocyte to monocyte ratio and survival in diffuse large B-cell lymphoma","volume":"20","author":"Porrata","year":"2014","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jcyt.2024.12.007_bib0040","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1002\/jca.21611","article-title":"Autograft immune effector cells and survival in autologous peripheral blood hematopoietic stem cell transplantation","volume":"33","author":"Porrata","year":"2018","journal-title":"J Clin Apher"},{"key":"10.1016\/j.jcyt.2024.12.007_bib0041","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1186\/s12943-022-01657-y","article-title":"Myeloid-derived suppressor cells: an emerging target for anticancer chemotherapy","volume":"21","author":"Wu","year":"2022","journal-title":"Mol Cancer"},{"key":"10.1016\/j.jcyt.2024.12.007_bib0042","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1182\/blood-2010-05-283820","article-title":"Immunosuppressive CD14+HLA-DR (low)\/- monocytes in B-cell non-Hodgkin lymphoma","volume":"117","author":"Lin","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.jcyt.2024.12.007_bib0043","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/s12575-018-0069-6","article-title":"Antitumor efficacy of human monocyte-derived dendritic cells. Comparing effects of two monocyte isolation methods","volume":"20","author":"Marques","year":"2018","journal-title":"Biol Proced Online"},{"key":"10.1016\/j.jcyt.2024.12.007_bib0044","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1182\/blood.V98.3.579","article-title":"Early lymphocyte recovery predicts superior survival after autologous hematopoietic stem cell transplantation in multiple myeloma or non-Hodgkin lymphoma","volume":"98","author":"Porrata","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.jcyt.2024.12.007_bib0045","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1002\/hon.2332","article-title":"Clinical impact of early recovery of peripheral blood absolute lymphocyte count after frontline autologous stem cell transplantation for diffuse large B-cell lymphoma","volume":"35","author":"Kim","year":"2017","journal-title":"Hematol Oncol"},{"key":"10.1016\/j.jcyt.2024.12.007_bib0046","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1159\/000531799","article-title":"CD34+ mobilization, autograft cellular composition and outcome in mantle cell lymphoma patients","volume":"50","author":"Turunen","year":"2023","journal-title":"Transfus Med Hemother"},{"key":"10.1016\/j.jcyt.2024.12.007_bib0047","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1002\/ajh.21314","article-title":"High CD8+ lymphocyte dose in the autograft predicts early lymphocyte count recovery after peripheral hematopoietic stem cell transplantation","volume":"84","author":"Atta","year":"2009","journal-title":"Am J Hematol"},{"key":"10.1016\/j.jcyt.2024.12.007_bib0048","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1016\/j.bbmt.2016.01.024","article-title":"Immunologic autograft engineering and survival in non-Hodgkin lymphoma","volume":"22","author":"Porrata","year":"2016","journal-title":"Biol Blood Marrow Transplant"},{"issue":"4","key":"10.1016\/j.jcyt.2024.12.007_bib0049","doi-asserted-by":"crossref","first-page":"501","DOI":"10.3109\/14653249.2012.655421","article-title":"Lymphocyte subset analysis for the assessment of treatment-related complications after autologous stem cell transplantation in multiple myeloma","volume":"14","author":"Lee","year":"2012","journal-title":"Cytotherapy"},{"key":"10.1016\/j.jcyt.2024.12.007_bib0050","doi-asserted-by":"crossref","first-page":"583","DOI":"10.3389\/fimmu.2015.00583","article-title":"NK cell subgroups, phenotype, and functions after autologous stem cell transplantation","volume":"6","author":"Jacobs","year":"2015","journal-title":"Front Immunol"},{"key":"10.1016\/j.jcyt.2024.12.007_bib0051","doi-asserted-by":"crossref","first-page":"2550","DOI":"10.3390\/cancers16142550","article-title":"Predictive factors for early immune recovery in patients with NHL after autologous transplantation: a multicenter prospective study","volume":"16","author":"Partanen","year":"2024","journal-title":"Cancers"},{"key":"10.1016\/j.jcyt.2024.12.007_bib0052","doi-asserted-by":"crossref","first-page":"3961","DOI":"10.1182\/blood.V86.10.3961.bloodjournal86103961","article-title":"An analysis of engraftment kinetics as a function of the CD34 content of peripheral blood progenitor cell collections in 692 patients after the administration of myeloablative chemotherapy","volume":"86","author":"Weaver","year":"1995","journal-title":"Blood"},{"key":"10.1016\/j.jcyt.2024.12.007_bib0053","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1182\/blood.V85.2.588.588","article-title":"Peripheral blood stem cell transplants for multiple myeloma: identification of favorable variables for rapid engraftment in 225 patients","volume":"85","author":"Tricot","year":"1995","journal-title":"Blood"},{"key":"10.1016\/j.jcyt.2024.12.007_bib0054","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1038\/sj.bmt.1703575","article-title":"Number of viable CD34(+) cells reinfused predicts engraftment in autologous hematopoietic stem cell transplantation","volume":"29","author":"Allan","year":"2002","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jcyt.2024.12.007_bib0055","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1016\/j.ejca.2004.01.029","article-title":"Factors influencing haematological recovery following high-dose chemotherapy and peripheral stem-cell transplantation for haematological malignancies; 1-year analysis","volume":"40","author":"Nieboer","year":"2004","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.jcyt.2024.12.007_bib0056","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1016\/j.bbmt.2010.11.021","article-title":"Transplanted CD34(+) cell dose is associated with long term platelet recovery following autologous peripheral blood stem cell transplant in patients with non-Hodgkin lymphoma or multiple myeloma","volume":"17","author":"Stiff","year":"2011","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jcyt.2024.12.007_bib0057","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1016\/j.bbmt.2009.06.018","article-title":"Failure to achieve a threshold dose of CD34+CD110+ progenitor cells in the graft predicts delayed platelet engraftment after autologous stem cell transplantation for multiple myeloma","volume":"15","author":"Wallington-Beddoe","year":"2009","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jcyt.2024.12.007_bib0058","doi-asserted-by":"crossref","first-page":"3141","DOI":"10.1182\/blood.V91.9.3148","article-title":"High CD34(+) cell counts decrease hematologic toxicity of autologous peripheral blood progenitor cell transplantation","volume":"91","author":"Ketterer","year":"1998","journal-title":"Blood"},{"key":"10.1016\/j.jcyt.2024.12.007_bib0059","doi-asserted-by":"crossref","first-page":"2191","DOI":"10.1007\/s12032-011-0029-3","article-title":"Autologous hematopoietic stem cell transplantation in multiple myeloma and lymphoma: an analysis of factors influencing stem cell collection and hematologic recovery","volume":"29","author":"Ungerstedt","year":"2012","journal-title":"Med Oncol"},{"key":"10.1016\/j.jcyt.2024.12.007_bib0060","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1002\/jca.22022","article-title":"Impact of the number of cryopreserved CD34+ cells in blood grafts infused on hematologic recovery and survival in myeloma patients after autologous stem cell transplantation: experience from the GOA study","volume":"38","author":"Partanen","year":"2023","journal-title":"J Clin Apher"},{"key":"10.1016\/j.jcyt.2024.12.007_bib0061","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1016\/j.jcyt.2023.05.015","article-title":"Adverse impact of delay of platelet recovery after autologous hematopoietic cell transplantation for aggressive non-Hodgkin lymphoma and multiple myeloma","volume":"25","author":"Okada","year":"2023","journal-title":"Cytotherapy"},{"issue":"4","key":"10.1016\/j.jcyt.2024.12.007_bib0062","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1038\/s41591-023-02273-z","article-title":"Motixafortide and G-CSF to mobilize hematopoietic stem cells for autologous transplantation in multiple myeloma: a randomized phase 3 trial","volume":"29","author":"Crees","year":"2023","journal-title":"Nat Med"},{"key":"10.1016\/j.jcyt.2024.12.007_bib0063","article-title":"Loss of CD34+ cells and effect of the number of viable cryopreserved CD34+ cells in the infused blood grafts on hematologic recovery, progression-free survival, and overall survival in patients with NHL after autologous stem cell transplantation","volume":"23","author":"Partanen","year":"2023","journal-title":"Clin Lymphoma Leuk Myel"},{"key":"10.1016\/j.jcyt.2024.12.007_bib0064","first-page":"S134","article-title":"Effect of cryopreservation on the CD34+ cell counts and T lymphocyte subsets in autologous blood grafts in patients with non-Hodgkin lymphoma or multiple myeloma","volume":"51","author":"Valtola","year":"2016","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jcyt.2024.12.007_bib0065","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1111\/j.1365-2141.2004.04951.x","article-title":"Infused CD34 cell dose, but not tumour cell content of peripheral blood progenitor cell grafts, predicts clinical outcome in patients with diffuse large B-cell lymphoma and follicular lymphoma grade 3 treated with high-dose therapy","volume":"125","author":"Blystad","year":"2004","journal-title":"Br J Haematol"},{"issue":"8","key":"10.1016\/j.jcyt.2024.12.007_bib0066","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1038\/sj.bmt.1705298","article-title":"Poor mobilization is an independent prognostic factor in patients with malignant lymphomas treated by peripheral blood stem cell transplantation","volume":"37","author":"Pavone","year":"2006","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jcyt.2024.12.007_bib0067","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1038\/sj.bmt.1705763","article-title":"Patients mobilizing large number of CD34+ cells (\u2018super mobilizers\u2019) have improved survival in autologous stem cell transplantation for lymphoid malignancies","volume":"40","author":"Bolwell","year":"2007","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jcyt.2024.12.007_bib0068","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1038\/sj.bmt.1705708","article-title":"Difficult stem cell mobilization despite adequate CD34+ cell dose predicts shortened progression free and overall survival","volume":"40","author":"Tomblyn","year":"2007","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jcyt.2024.12.007_bib0069","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1111\/trf.16198","article-title":"Mobilization characteristics, blood graft composition, and outcome in diffuse large B-cell lymphoma after autologous stem cell transplantation: results from the multicenter prospective GOA study","volume":"61","author":"Partanen","year":"2021","journal-title":"Transfusion"},{"key":"10.1016\/j.jcyt.2024.12.007_bib0070","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1186\/s13045-015-0178-5","article-title":"Infused autograft lymphocyte to monocyte ratio and survival in T-cell lymphoma post-autologous peripheral blood hematopoietic stem cell transplantation","volume":"8","author":"Porrata","year":"2015","journal-title":"J Hematol Oncol"},{"key":"10.1016\/j.jcyt.2024.12.007_bib0071","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1080\/14653240802165665","article-title":"The role of stem cell mobilization regimen on lymphocyte collection in patients with multiple myeloma","volume":"10","author":"Hiwase","year":"2008","journal-title":"Cytotherapy"},{"key":"10.1016\/j.jcyt.2024.12.007_bib0072","first-page":"S3","article-title":"Autograft monocytes. The bad humors of autologous peripheral blood hematopoietic stem cell transplantation","author":"Ansell","year":"2013","journal-title":"J Stem Cell Res Ther"},{"key":"10.1016\/j.jcyt.2024.12.007_bib0073","doi-asserted-by":"crossref","first-page":"2115","DOI":"10.1080\/10428194.2019.1581929","article-title":"Importance of early immune recovery after autologous hematopoietic cell transplantation in lymphoma patients","volume":"60","author":"Jantunen","year":"2019","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.jcyt.2024.12.007_bib0074","article-title":"Autologous graft-versus-tumor effect: reality or fiction?","volume":"2016","author":"Porrata","year":"2016","journal-title":"Adv Hematol"},{"key":"10.1016\/j.jcyt.2024.12.007_bib0075","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1002\/jca.20259","article-title":"Use of various offset settings in the Fenwal Amicus during hematopoietic progenitor cell collection to increase lymphocyte yield and reduce cross-cellular contamination","volume":"25","author":"Burgstaler","year":"2010","journal-title":"J Clin Apher"},{"key":"10.1016\/j.jcyt.2024.12.007_bib0076","article-title":"Interleukin-15 affects patients\u2019 survival through natural killer cell recovery after autologous hematopoietic stem cell transplantation for non-Hodgkin lymphoma","volume":"2010","author":"Porrata","year":"2010","journal-title":"Clin Develop Immunol"},{"key":"10.1016\/j.jcyt.2024.12.007_bib0077","first-page":"1341","article-title":"How we manufacture clinical-grade interleukin-15-stimulated natural killer cell products for cancer treatment","volume":"58","author":"Fernendez","year":"2018","journal-title":"Transfusion"},{"key":"10.1016\/j.jcyt.2024.12.007_bib0078","doi-asserted-by":"crossref","first-page":"5641","DOI":"10.1182\/bloodadvances.2021005883","article-title":"Evaluation of allogeneic and autologous membrane-bound IL-21\u2212expanded NK cells for chronic lymphocytic leukemia therapy","volume":"6","author":"Yano","year":"2022","journal-title":"Blood Adv"},{"key":"10.1016\/j.jcyt.2024.12.007_bib0079","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.3389\/fimmu.2019.01147","article-title":"The CD14+HLA-DRlow\/neg monocyte: an immunosuppressive phenotype that retrains responses to cancer immunotherapy","volume":"10","author":"Mengos","year":"2019","journal-title":"Front Immunol"}],"container-title":["Cytotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S146532492400968X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S146532492400968X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,4,12]],"date-time":"2025-04-12T08:24:38Z","timestamp":1744446278000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S146532492400968X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4]]},"references-count":79,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,4]]}},"alternative-id":["S146532492400968X"],"URL":"https:\/\/doi.org\/10.1016\/j.jcyt.2024.12.007","relation":{},"ISSN":["1465-3249"],"issn-type":[{"value":"1465-3249","type":"print"}],"subject":[],"published":{"date-parts":[[2025,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Autograft composition and outcome\u2014towards an optimal graft?","name":"articletitle","label":"Article Title"},{"value":"Cytotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcyt.2024.12.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 International Society for Cell & Gene Therapy. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}